Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DNLI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
DNLI stock price ended at $13.99 on Wednesday, after rising2.79%
The Denali Therapeutics Inc stock price increased by 2.79% on the last trading day (30 Jul 2025), rising from 13.75 to 13.61. Throughout the last trading session, the stock experienced a fluctuation of 2.11% , ranging from a day low of $13.52 to a day high of 13.805. The price has declined in 7 of the last 10 days, resulting in a total change of -3.95% during this period. On the last day, trading volume increase by 154.00K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.56M shares were traded, amounting to approximately 21.26M.
DNLI Technical Signals
DNLI(Denali Therapeutics Inc Corp) has 4 buy signals and 4 sell signals now. The current trend is consolidation starting from 2025-07-22. The total price change during this trend is -1.87%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of DNLI over the last 5 trading days is 19.59M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
Denali Therapeutics Inc's overall moving average trend leans more bearish as of Wednesday, July 30, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $15.26, and $15.88. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $13.24, and $12.62. A break-down below any of these levels will issue sell signals.
DNLI Short Selling Analysis
The short sale ratio of Denali Therapeutics Inc(DNLI) as of 28 Jul 2025 is 20.82%, rising from last trading day. With increasing price from 13.67 to 13.63. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Neutral
Sell
4
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
2.002
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-152.136
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
-0
Bullish
Williams %R (14 days)
WILLR_14 < -80
-95.148
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
DNLI Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Denali Therapeutics Inc(DNLI), our algorithm predicts DNLI's 1-month price at $15.49, with an 5.42%upwardshift. Using a similarity score up to 93.02%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Denali Therapeutics Inc (DNLI.O) stock, as of Sunday, July 6, 2025 , forecasts a 5.42% change over the next month, based on its high correlation with CNQ.N stock patterns. The similarity between their price movements over the analyzed periods is 93.02%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
Based on DNLI's historical stock price data across all years, the probability of a positive return in July is37.50%, suggesting it maynotbe an ideal month to invest in DNLI. In contrast,Mayoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Denali Therapeutics Inc (DNLI.O) stock in May has the highest probability of a positive return (75.00%), while March has the lowest probability (25.00%).
Performance Seasonality
The chart shows Denali Therapeutics Inc. (DNLI)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Denali Therapeutics Inc (DNLI.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. DNLI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Denali Therapeutics Inc (DNLI.O) stock in a year?
The radar chart shows that buying Denali Therapeutics Inc (DNLI.O) stock in May has the highest probability of a positive return (75.00%), while March has the lowest probability (25.00%).
How has Denali Therapeutics Inc. (DNLI)'s stock price performed over the past three years?
DNLI's stock price fell by -22.33% in 2023,decreased by -4.72% in 2024, and went down by 32.87%in 2025.
Bearish technical signals of DNLI include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1.
Is DNLI a buy based on overall technical signals summary?
DNLI has 4 buy signals and 4 sell signals now. Overall the technical rating for DNLI is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of DNLI.
What is the trend of Denali Therapeutics Inc (DNLI)'s moving average?
Denali Therapeutics Inc's overall moving average trend leans more bearish as of July 30 2025, with 2 negative signals and 2 positive signal.
What is price prediction for DNLI stock next month?
The price prediction chart for Denali Therapeutics Inc (DNLI.O) stock, as of July 06 2025, forecasts a 5.42% change over the next month, based on its high correlation with CNQ stock patterns. The similarity between their price movements over the analyzed periods is 93.02%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for DNLI Stock?
The predicted price target for DNLI stock in 2025 is **$32.44**, based on the average analyst price target. This prediction is supported by positive analyst sentiment and recent regulatory progress, including the initiation of a biologics license application (BLA) for Tividenofusp Alfa, which could drive future growth.
What is price prediction 2030 for DNLI Stock?
The price prediction for DNLI stock in 2030 is expected to range between $250 and $300 per share. This forecast is based on the company's promising pipeline in neurodegenerative treatments and potential market share gains.